ArticleFrontiers in neurology2025
Evaluation of small vessel disease burden on MRI and stroke outcomes.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- LBMNet: a hybrid multi-scale CNN-Mamba framework for enhanced 3D stroke lesion segmentation in MRI.Frontiers in medicine · 2026Article
- Relationship between impaired cerebral lymphatic function and iron deposition, blood flow in VaD: a clinical MRI study.Frontiers in neuroscience · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: We aimed to assess whether a composite SVD score derived from MRI features improves stroke outcome prediction when integrated with clinical factors. Materials and methods: A 2019-2022 retrospective analysis included patients who had MRI prior to stroke admission. A semi-automated approach evaluated SVD MRI markers (white matter hyperintensities (WMH), lacunar infarcts, perivascular spaces (PVS), and cerebral microbleeds (CMBs)) using continuous and categorical measures to create a composite SVD score. Multivariate regression analyses compared performance across three models: (1) SVD score, (2) clinical factors, and (3) SVD score + clinical factors for outcomes, including stroke etiology, ICU and hospital stay, NIH Stroke Scale (NIHSS), 90 day modified Rankin Scale (mRS), functional independence (mRS < 2), and stroke recurrence. Results: Forty-eight patients were included in this study. The combined SVD + clinical factors model outperformed other models in predicting functional independence with area under the curve (AUC) 0.58 (95% CI 0.41-0.75) and stroke etiologies of large artery atherosclerosis AUC 0.78 (0.62-0.91), small vessel occlusion 0.65 (0.41-0.88), and other determined etiology 0.74 (0.37-0.96). The combined model also better predicted the following outcomes with lower mean absolute error (MAE): NIHSS MAE 5.16 (3.80-6.69), ICU days 1.26 (0.86-1.66), total length of stay 2.62 (2.08-3.17), and 90 day mRS 1.74 (1.39-2.12). Conclusion: Combining an SVD score with clinical variables improved prediction of stroke outcomes when compared to either predictor alone, although the added value is modest and requires further validation. Nonetheless, integrating an SVD score into clinical practice may guide management in acute stroke settings and support risk stratification and prognostication.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.